What was once seen as a 'profit center' is now seen as a 'cost center'
May hold potential for use with targeted biopsies and radiotherapy
RSNA session addresses an increasing demand for caution
Also unveils FDA-pending, real-time needle biopsy and verification system
Although well paid, many radiologists struggle to be happy